Eshetu G. Atenafu
Papers
5
Total Citations
104
H-Index
3
About
Eshetu G. Atenafu is a biostatistician and clinical researcher whose work spans radiation oncology, surgical oncology, and cancer staging methodologies. Based primarily at the University Health Network in Toronto, Atenafu has made significant contributions to improving precision and reproducibility in cancer treatment and surgical outcomes research. Among Atenafu's most recognized contributions is a 2018 investigation into head immobilization devices for stereotactic radiosurgery and radiotherapy, which has garnered 62 citations and provided critical guidance on the safety and accuracy of frameless versus frame-based systems for linac-based SRS—a clinically impactful finding as noninvasive systems have become increasingly prevalent. Complementing this work, a 2019 study evaluated the efficacy of rotational corrections in head and neck image-guided radiotherapy, further refining treatment delivery protocols. Atenafu has also applied rigorous propensity-matched and retrospective cohort analyses to surgical oncology, including comparative studies of open versus robotic retroperitoneal lymph node dissection for testicular cancer and lymphadenectomy approaches for high-risk endometrial cancer. Notably, research into lymph node density as a prognostic relapse marker highlights Atenafu's ongoing interest in refining oncological risk stratification. Through methodologically sophisticated analyses, Atenafu continues to shape evidence-based practices across multiple cancer treatment domains.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5